Interleukin-13 (IL-13) belongs to the IL-4 gene family. Like IL-4, IL-13 induces IL-1 receptor antagonist [IL-1Ra) synthesis with no effect on IL-1p synthesis. We investigated whether IL-13 induces IL-1Ra synthesis via a pathway similar to IL-4. In human peripheral blood mononuclear cells, IL-13 (1 to 100 ng/mL) alone induced IL-1Ra synthesis in a dose-dependent manner. A single amino acid mutant form of IL-4 (hlL-4.V124D) induced IL-1Ra synthesis, acting as a partial agonist. However, hlL-4.Vl24D inhibited IL-1Ra synthesis induced by either IL-4 or IL-13. IL-13 alone induced accumulation of IL-1Ra mRNA. Furthermore, IL-13 reduced steadystate levels for IL-1p mRNA but enhanced those for IL-1Ra NTERLEUKIN-13 (IL-13), a IO-kD polypeptide secreted I by activated T cells and mast cells, has multiple biologic activities on human B cells and monocytes.'-5 IL-13 promotes growth of preactivated B cells: induces germline E transcripts and directs naive B cells to switch to IgE and IgG4 synthesk6 IL-I 3 induces expression of the low-affinity receptor for IgE (FceRIIICD23) and upregulates class I1 major histocompatibility complex (MHC) expression on both B cells and monocyte^.^.^ In monocytes, IL-13 downregulates Fcy receptor surface expression7 and inhibits synthesis of inflammatory cytokines, including tumor necrosis factor a, IL-lp, IL-6, and IL-8."' Moreover, IL-13 suppresses synthesis of IL-12,7 a critical cytokine for differentiation of uncommitted T cells towards the Th, phenotype!" Interestingly, all these biologic activities are shared with IL-4." Like IL-4, IL-13 may thus favor humoral over cell-mediated immunity.
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IL-4 reduces IL-I activity by both inducing synthesis of IL-1 receptor antagonist (IL-IRa) in resting monocyte^"^'^ and enhancing IL-1Ra synthesis in activated monocyte^.'^^'^.'^ IL-1Ra is a naturally occumng polypeptide with significant amino acid homology to IL-la and IL-lp'7-'9 and is a member of the IL-1 gene family." IL-1Ra binds to both type I and type I1 IL-1 without agonist activity," prevents IL-1 binding to its receptors, and inhibits IL-1 biologic
We have recently shown that IL-13, like IL-4, enhances IL-1Ra synthesis in lipopolysaccharide (LPS)-stimulated monocytes, but suppresses IL-lp synthesis in the same cells.7 More recently, Muzio et aIz5 have shown that IL-13 induces IL-1Ra synthesis in resting monocytes. However, these investigators suggested that IL-13, unlike IL-4, increases IL-I Ra mRNA stability rather than IL-1Ra gene transcription. We now report that a single amino acid mutant form of IL-4 (hIL-4.Yl24D) is a weak inducer of IL-1Ra synthesis in human peripheral blood mononuclear cells (PBMC). However, hIL-4.Yl24D inhibits IL-1Ra synthesis induced by either IL-13 or IL-4, indicating that both cytokines induce IL-1Ra synthesis via binding to a common subunit of their respective receptors. Accordingly, IL-13, like IL-4, enhanced IL-1Ra mRNA steady-state levels in PBMC stimulated with either LPS or IL-la, but failed to affect IL-1Ra mRNA stability. Furthermore, IL-13, like IL-4, induced transcriptional activation of the IL-1Ra gene, but reduced spontaneous IL-1P gene transcription.
In addition to its inhibitory effect on IL-1P
mRNA in cells stimulated with lipopolysaccharide (LPS) or IL-la. Accordingly, IL-13 suppressed IL-lfl synthesis but enhanced IL-1Ra synthesis in these cells. IL-13 reduced the stability of IL-1p mRNA (2.9 v 1.7 hours) but failed to modify the stability of IL-1Ra mRNA (2.7 v2.5 hours). Moreover, IL-13 induced transcriptional activation of the IL-1Ra gene, but reduced IL-lP gene transcription. Our results suggest that the commonality between IL-13 and IL-4 in inducing IL-1Ra synthesis results from the engagement of a subunit common to both receptors. 0 1996 by The American Society of Hematology.
MATERIALS AND METHODS

Reagents.
Human and mouse recombinant IL-13 were generated and purified as de~cribed.~ Human recombinant IL-4 was a gift from Dr T. Nagabhushan (Schering-Plough, Bloomfield, NJ). The human IL-4 mutant protein hIL-4.Y124D, in which Tyr at position 124 was replaced by Asp, was produced and purified as described.26 Endotoxin levels, as determined by the Limulus amebocyte lysate assay (Whittaker M.A. Bioproducts, Walkersville, MD), were typically less than 25 endotoxin unitslml. Purity of these recombinant proteins was higher than 95%. Human recombinant IL-la was provided by Genzyme, Inc (Cambridge, MA). LPS from Escherichia coli 055:B5 was purchased from Sigma Chemical Co (St Louis, MO).
Actinomycin D was purchased from Calbiochem (La Jolla, CA).
Blood was drawn from healthy human volunteers who had not ingested histamine receptor antagonists or cyclooxygenase inhibitors for at least 2 weeks, The study was approved by the Human Investigative Review Committee of the New England Medical Center Hospitals. PBMC were separated from heparinized blood by centrifugation on Ficoll-Hypaque (Ficoll Type 400 [Sigma]; Hypaque-M 90% [Winthrop Breon Laboratories, New York, NY]) gradients. Cells were washed twice in 0.15 m o m NaCl and resuspended at 5 X IO' cellslml in ultrafiltered RPMI culture medium 1640 (Whittaker M.A. Bioproducts) supplemented with 2 mmol/L L-glutamine, 100 U/mL penicillin, and 100 pglmL streptomycin (GIBCO Laboratories, Grand Island, NY). PBMC (2.5 x 10' cellslml in RPMI) were stimulated with LPS (10 ng/mL) or human IL-la (10 ng/mL) in the absence or presence of murine IL-13, human IL-13, or human IL-4. PBMC cultures (0.5 mL final volume) were incubated in 12 X 75 mm polypropylene round bottom tubes (Becton Human PBMC culture.
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Dickinson and Co, Lincoln Park, NJ) for 24 hours at 37°C in a humidified atmosphere containing 5% CO,.
In other experiments, PBMC were stimulated for 24 hours with either IL-4 (3 ng/mL) or IL-13 (30 ng/mL) in the absence or presence of the human IL-4 mutant protein hIL-4.Yl24D. Cells were exposed to hIL-4.Yl24D at the time of their stimulation by IL-4 or IL-13.
After incubation, cultures were subjected to three freeze-thaw cycles. This procedure is optimal for recovery and measurement of total (cell-associated + secreted) cytokines by specific RIA as described for IL-lP" and IL-1Ra." The sensitivities (defined as 95% binding) of the RIAs for IL-1P and IL-1Ra were typically 78 and 150 pg/mL, respectively. In one experiment, IL-1P levels were assessed using an enzyme-linked immunosorbent assay (ELISA) kit (Cistron Biotechnology, Pine Brook, NJ).
PBMC were stimulated for 6 hours at 37°C in 50 mL polypropylene tubes with either LPS (IO ng/mL) or ILl a (10 ng/mL) in the absence or presence of human IL-13 (100 ngl mL). Total cellular RNA was then extracted from PBMC by lysis with 4 m o w guanidium isothiocyanate, followed by ultracentrifugation on a 5.7 mol/L cesium chloride gradient.29 Total RNA (10 pg) was subjected to electrophoresis in 6.6% formaldehyde (Sigma) and 1.2% agarose (International Biotechnology Inc, New Haven, CT) gel and transferred to nylon membranes (Hybond-N; Amersham Corp, Arlington Heights, IL) by capillary blotting. The membranes were exposed to short-wave UV light for 5 minutes to fix the RNA to the nylon matrix and treated for 2 hours at 42°C with prehybridization solution. Membranes were then treated at 42°C overnight with prehybridization solution containing 32 P-labeled nucleic acid probe. The probes used were a 600-bp fragment of human IL-IRa cDNA subcloned into pUC8, a 1,075-bp fragment of human IL-lP precursor cDNA subcloned into pGEM2, and the full length of chicken pactin cDNA subcloned in pGEM3 (gift of Dr Brigitte Huber, Tufts University, Boston, MA). The DNA was labeled with 32 P-dCTP (3,000 Ci/mmol; New England Nuclear, Boston, MA) using a random-primed DNA labeling kit (Boehringer Mannheim, Mannheim, Germany). After incubation, membranes were washed in 0.1 % sodium dodecyl sulfate (SDS), l~ SSC at 42°C. Washed membranes were exposed to x-ray film (XAR5; Kodak, Rochester, NY) at -70°C with an intensifying screen.
Reverse transcripfase-polymerase chain reaction (RT-PCR). PBMC were stimulated for 1.5, 3, 6, 12, or 24 hours at 37°C with LPS ( I O ng/mL) in the absence or presence of human IL-13 (100 ng/mL). Total cellular RNA was extracted by lysis with Tri-Reagent (Molecular Research Center, Cincinnati, OH) followed by a back-extraction with chloroform and precipitation in isopropanol. Total RNA (300 ng) was reverse transcribed in a buffer (5 mmolL MgCI2, 50 mmoVL KCI, 10 mmol/L Tris-HC1, pH 8.3) containing 2.5 pmol/L random hexamers, 1 mmol/L dNTP, IU/pL RNase inhibitor, and 2.5 U/pL murine leukemia virus reverse transcriptase (Perkin-Elmer, Norwalk, CT). Random hexamers were allowed to be extended for IO minutes at 24°C and total RNA was subsequently reverse transcribed at 42°C for 30 minutes. Inactivation of the reverse transcriptase was achieved by heating samples at 99°C for 5 minutes. cDNAs were then amplified using primers specific for the secreted form of IL-1Ra (sense primer, 5'-CACTCTCCTCCTCTI'CCT-GTI'C-3'; antisense primer, 5'-GCTTGTCCTGTCTTCTGTTCTC-3'). IL-10 (sense primer, 5'-ATGGCAGAAGTACCTAAGCTCGC-3'; antisense primer, 5'-ACACAAATTGCATGGTGAAGTCA-GTT-3'), or glyceraldehyde-3-phosphate dehydrogenase (G3PDH; sense primer, 5 ' -TGAAGGTCGG AGTC AACGGAT'ITGGT-3 ' ; antisense primer, 5'-CATGTGGGCCATGAGGTCCACCAC-3'). 
Northern analysis.
of each specific primer. First strand cDNAs were amplified for 24 cycles using IL-1Ra primers, 20 cycles using IL-Ip primers, and 30 cycles using G3PDH primers. Amplification was performed as follows: 1 cycle at 94°C for 1 minute; followed by 20-30 cycles at 94°C for 1 minute, 60°C for 1 minute, 72°C for 2 minutes; and I cycle at 72°C for 7 minutes. Amplified products were subjected to electrophoresis in 1.5% agarose gel containing ethidium bromide (0.3 pg/mL). Product size was compared to molecular weight standards (1 kb DNA ladder from GIBCO Life Technologies). The molecular weight markers shown in lanes "L" of Fig 7 contain the following number of base pairs: 2036, 1636, 1018, the doublet 517/ 506, 396, 344, and 298 (from top to bottom).
PBMC (4 X lo7 cells per condition) were stimulated for 3 hours at 37°C with either human IL-13 (100 ng/mL) or human IL-4 (IO ng/mL). Cells were lysed in ice-cold hypotonic buffer ( I O mmol/L HEPES pH 7.6, 10 mmoYL NaCl, 3 mmol/L MgC1,) containing 0.5% Nonidet P-40. Nuclei were pelleted at 760g for 5 minutes at 4°C and resuspended in 50 pL of ice-cold freezing buffer (40% glycerol, 50 mmoVL HEPES, pH 7.6, 5 mmoV L MgCIZ, 0.1 m m o K EDTA). Nuclei suspensions were then added to 35 pL of transcription reaction mix [12.14 mmoVL HEPES, pH 7.6, 6.07 mmoVL MgCI2, 0.36 mmol/L KCl, 0.8 mom (NH,),SO,, 2.43 mg/mL heparin, 1.14% sarkosyl, 0.71 UlpL RNAsin, 5.71 mmoUL DTT] containing 1 mmoK ATP, 1 mmoUL CTP, 1 mmoUL GTP, and 50 pCi a3'P-UTP (3,000 Ci/mmol; New England Nuclear) and incubated for 30 minutes at 30°C. The reaction mix was then incubated for 30 minutes at 30°C in the presence of RNase-free DNAse I (54 pg/mL) to ensure complete DNA degradation. Proteins were subsequently digested by proteinase K (0.52 mg/mL) during an incubation at 50°C for 1 hour. Nuclear transcripts were added with yeast tRNA and ammonium acetate and extracted with a mixture of phenolkhlorofordisoamyl alcohol. The upper aqueous phase was then extracted with chloroform and precipitated in ice-cold 100% ethanol. RNA was resuspended in diethylpyrocarbonate (DEPC)-treated water and purified through two additional cycles of neutralization with ammonium acetate, precipitation in 100% ethanol, and washes in 70% ethanol. After the first of these two cycles, RNA was resuspended in DNAse buffer (200 U/mL RNAsin, 5 mmolL MgCI2. 1 mmol/L CaCl,, 20 m m o K HEPES, pH 7.6) containing RNAse-free DNAse I (33 ng/mL). After the last of these two cycles, RNA was resuspended in DEPC-treated water. Nuclear transcripts were hybridized at 42°C for 48 hours to nitrocellulose filters on which 5 pg of denatured plasmid DNA had been immobilized. The probes were a 900-bp fragment of human IL-1Ra cDNA subcloned in Bluescript (gift of Dr Michael F. Smith Jr, University of Colorado Health Sciences Center, Denver, CO), the full length of human ILl p precursor cDNA subcloned in the Okayama-Berg expression vector, and the full-length chicken P-actin cDNA subcloned in pGEM3. pGL2 basic was used as an intemal control vector (Promega, Madison, WI). Filters were washed 4 times in 0.1 % SDS, 2X SSC for 30 minutes at 65°C and twice in 2X SSC for 10 minutes at 25°C. Filters were subsequently washed in 2X SSC containing 10 pg/mL RNase A for 30 minutes at 25°C and 4 times in 2X SSC for 2 to 3 minutes at 25°C. Washed filters were exposed to x-ray film for 2 days at -70°C with an intensifying screen.
Data are expressed as mean -C SEM of the indicated number of experiments. Differences between cytokinetreated groups and RPMI-treated groups were analyzed for significance by Student's f-test for paired samples or two-way analysis of variance (ANOVA).
Nuclear run-on assays.
Statistical analysis.
RESULTS
IL-13 induces IL-IRa synthesis. In human PBMC, murine IL-13 alone did not induce IL-ID synthesis (data not
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shown) but rather stimulated IL-IRa synthesis in a dosedependent manner (Fig I) . IL-13 at 10 ng/mL induced significant amounts of IL-IRa (1.52 ? 0.47 ng/mL, P < .01) when compared with basal levels (0.48 ? 0.10 ng/mL, n = 3). A further increase in IL-IRa synthesis was observed when IL-13 was used at either 100 ng/mL (3.28 ? 0.45 ng/ mL, P < .001) or 500 ng/mL (4.68 ? 0.47 ng/mL, P < .001). Moreover, IL-IRa levels induced by IL-13 at 500 ng/ mL were significantly higher (P < .01) than those observed for IL-13 at 100 ng/mL. Because in vivo levels of IL-13 are unlikely to be as high as SO0 ng/mL, regulation of cytokine synthesis was subsequently studied using IL-I3 at concentrations up to 100 ng/mL.
We next compared the potencies of human and murine IL-13 in our in vitro model. IL-IRa synthesis was induced to the same extent by murine IL-13 (3.55 ? 0.22 ng/mL) and human IL-13 (4.57 ? 0.80 ng/mL, n = 4, P > .OS) when used at the same concentration of 100 ng/mL. ever, at 100 ng/mL, IL-13 both enhanced IL-IRa synthesis (33% increase, P < .001) and reduced IL-Ip synthesis (69% inhibition, P < .01). Similar effects of IL-13 at 100 ng/mL were observed when PBMC were stimulated with LPS either at l00pg/mL (22% increase IL-IRa, P < .01; 73% inhibition IL-Ip, P < .05; n = 6) or IO ng/mL (22% increase IL-lRa, P < .001; 64% inhibition IL-Io, P < .001; n = IO).
We also investigated the effect of IL-13 on IL-1 Ra and ILIp synthesis in IL-l -stimulated cells. Unstimulated PBMC cultures contained IL-IRa at 0.56 ? 0.06 ng/mL and IL-ID at less than 0.08 ng/mL (n = 7). IL-la ( I O ng/mL) stimulated synthesis of both IL-IRa (3.34 5 0.69 ng/mL) and IL-Io (1.06 2 0.20 ng/mL). IL-13 differentially regulated IL-lainduced synthesis of IL-IRa and IL-ID (Fig 5) . IL-13 at IO ng/mL marginally enhanced IL-1 Ra synthesis (22% increase, 18. PBMC were stimulated for 24 hours with LPS (1 ng/mL) in the absence or presence of murine IL-13 (1 to 100 ng/mL). Differences in IL-1Ra or IL-1p synthesis were analyzed for significance by ANOVA (*P < .05; **P < .01; ***P < .OOl). Data are expressed as mean k SEM for six donors. 100 ng/mL, IL-13 significantly enhanced IL-IRa synthesis (79% increase, P < .001) but also markedly inhibited ILl p synthesis (83% inhibition, P < .001).
Effect of IL-13 on steady-state levels for IL-IRa and IL-I p mRNA in LPS-or IL-la-stimulated PBMC. After 6
hours of culture, unstimulated PBMC did not express detectable levels of mRNA for IL-ID or IL-IRa (Fig 6) . IL-Ip and IL-IRa protein levels from these cultures were 0.08 and 0.48 ng/mL, respectively. IL-13 alone (100 ng/mL) increased IL-IRa mRNA levels and induced IL-1Ra protein synthesis (2.17 ng/mL). However, IL-13 induced neither IL-Ip protein synthesis nor accumulation of IL-ID mRNA. IL-13 markedly suppressed IL-ID mRNA accumulation in cells stimulated with LPS or IL-la (Fig 6) . Accordingly, IL-13 reduced IL-ID synthesis induced by either stimulus. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 1Ra mRNA accumulation. In these cells, IL-13 also enhanced IL-IRa synthesis. However, we did not observe a significant increase in steady-state levels for IL-I Ra mRNA 6 hours (Fig 6) or 16 hours (data not shown) after cell 331 1 stimulation with IL-la. Nevertheless, IL-l Ra mRNA levels in IL-la-stimulated cells were marginally enhanced in the presence of IL-13 when compared with those observed in cells stimulated with IL-13 alone (Fig 6) . In the same cell cultures, 1L-13 and IL-la had additive effects on IL-IRa synthesis.
Time-course of IL-IRa and IL-ID gene expression in LPS-stimulated PBMC: effect of IL-13. Because monocytes primarily express the secreted form of IL-IRa over its intracellular counterpart,''' we studied the effect of IL-13 on steady-state levels of mRNA coding for the secreted form of IL-IRa using the RT-PCR technique (Fig 7) . IL-13 alone (100 ng/mL) induced a rapid accumulation of IL-I Ra mRNA in PBMC (upper row, left panel). IL-IRa mRNA levels increased as early as 1.5 hours after exposure to IL-13 and reached peak levels within the first 3 hours of stimulation. The accumulation of IL-IRa mRNA was transient because IL-IRa mRNA levels gradually returned to basal levels within 24 hours of culture. IL-IRa protein levels rapidly increased during the first 6 hours of exposure to IL-13 and gradually increased thereafter (upper histogram, left segment). In contrast, IL-13 failed to induce a detectable accumulation of IL-ID protein (lower histogram, left segment) or IL-ID mRNA (middle row, left panel) within the 24 hours of culture.
In LPS-stimulated PBMC, IL-13 enhanced IL-1 Ra mRNA and protein levels (Fig 7, upper row. middle and right panels). Accumulation of IL-1 Ra mRNA in LPS-stimulated cells was markedly increased in the presence of IL-13 at 1.5 and 3 hours of culture. This increase was also observed after 6 hours of culture, although to a lesser extent. Accordingly, IL-13 enhanced IL-IRa protein levels in LPS-stimulated cells at each time point throughout the 24 hours of culture (upper histogram, middle and right segments). In contrast, IL-13 reduced IL-IO mRNA in LPS-stimulated cells (middle row, middle and right panels). IL-I 3 remained without noticeable effect on IL-I D mRNA levels at the early time points of 1.5 and 3 hours. However, IL-13 markedly suppressed IL-10 mRNA levels in LPS-stimulated cells at 6. 12, and 24 hours of culture. A similar effect on IL-13 on LPS-induced IL-IO synthesis was observed (lower histogram, middle and right segments). IL-I 3 failed to modify accumulation of IL-ID protein within the first 3 hours after exposure to LPS, but dramatically suppressed any further IL-ID synthesis.
Effect of IL-13 on the stability oflL-IRa and IL-ID mRNA. Because unstimulated PBMC did not express detectable levels of IL-IRa mRNA, we studied the effect of IL-13 on IL1Ra mRNA stability in LPS-stimulated PBMC. Cells were stimulated for 6 hours with LPS ( I O ng/mL). Actinomycin D was then added to the cultures to block any further transcription. As shown in Fig 8, exponential regression analyses indicated that IL-13 (100 ng/mL) failed to affect the halflife of IL-IRa mRNA in LPS-stimulated cells (2.7 hours in the absence of IL-13 v 2.5 hours in the presence of IL-13). In contrast, IL-13 reduced the half-life of IL-ID mRNA in these same cells (2.9 hours in the absence of IL-13 v 1.7 hours in the presence of IL-13). 
c3
IL-13 failed to modify IL-IRa mRNA stability, we next investigated whether IL-13, like IL-4, could modulate IL-1 Ra gene expression at the transcriptional level. PBMC were stimulated for 3 hours with either IL-13 (100 ng/mL) or IL-4 (10 ng/mL). Nuclei were purified and nuclear run-on assays performed. As shown in Fig 9, Amplified products were subjected t o electrophoresis side with the 1-kb DNA ladder from GIBCO L l e Technologies (lane L in each panel). The expected PCR products for the secreted form of IL-1Ra. IL-lp, and GBPDH comprised 329,802, and 983 bp, respectively. Protein levels from PBMC cultures at the corresponding time points were assayed by RIA for IL1Ra and ELISA for IL-1p.
expected, IL-13 and IL-4 reduced the spontaneous transcriptional activation of the IL-10 gene.
DISCUSSION
In these studies, we show that 1L-13 has selective and reciprocal effects on the synthesis of two members of the IL-1 gene family, ie, IL-1 Ra and IL-ID. IL-13 alone induced mRNA and protein synthesis for IL-IRa, but not for IL-ID. Induction of IL-1Ra synthesis by IL-13 was observed at concentrations IO-fold higher that those required to observe a similar effect with IL-4.I3 Interestingly, IL-13 induces a rapid tyrosine phosphorylation and activation of raf-1 kinase in the human monocytic progenitor cell line U937 at a concentration of 0.1 ng/mL." However, a similar profile of protein phosphorylation is observed in human monocytes when concentrations of IL-13 are higher than 5 ng/mL. Because differences in responsiveness of human monocytes to IL-4 and IL-13 cannot be related to surface expression of IL4Ra, the common chain to their respective receptors, one might speculate that differentiation along the monocytic lineage is accompanied by a reduced expression of the IL-13 receptor chain or a decreased affinity of the IL-13 receptor complex.
IL-
IL-4 alone induces mRNA accumulation for IL-IRa by increasing transcriptional activity of the IL-I Ra gene with no effect on the half-life of its mRNA." Similarly, IL-4 enhances IL-1 Ra mRNA steady-state levels in LPS-stimulated monocytes without affecting mRNA In agreement with these findings, IL-I Ra mRNA does not contain AU-rich sequences typically found in the 3'-untranslated regions of unstable mRNAs.".I9 Recently, Muzio et 
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reported that IL-13 induces IL-1Ra synthesis by increasing the stability of its mRNA. Surprisingly, they based their conclusion on a comparison of the IL-1Ra mRNA half-life in unstimulated monocytes with that calculated from IL-13-stimulated cells. However, we were unable to observe any significant accumulation of IL-1Ra mRNA in unstimulated PBMC. We therefore investigated the effect of IL-13 on the stability of IL-1Ra mRNA in LPS-stimulated cells. In these cells, IL-13 failed to affect the half-life of IL-1Ra mRNA. However, like IL-4,I6 IL-13 reduced the half-life of IL-10 mRNA in LPS-stimulated cells. We then investigated the effect of IL-13 on transcriptional activity of the genes coding for IL-IRa and IL-IP. Like IL-4, IL-13 alone induced transcriptional activation of the IL-1Ra gene, but reduced the spontaneous IL-lP gene expression. These results are in agreement with the inhibitory activity of hIL-4.Y 124D on IL-1Ra synthesis induced by either IL-13 or IL-4 because the commonality of their regulatory effects on cytokine gene expression likely relies on their binding to a common receptor subunit critical for signal transduction.2h.'' IL-4 reduces self-induction of IL-1 and upregulates IL-1-induced synthesis of IL-1Ra.I' We now report that IL-13. like IL-4, differentially regulated IL-1Ra and IL-10 synthesis in IL-la-stimulated PBMC. Furthermore, IL-13 enhanced IL-1Ra mRNA accumulation in IL-la-stimulated cells but dramatically reduced IL-1P mRNA accumulation in these same cells. Similarly, IL-13 enhanced IL-1Ra mRNA levels in LPS-stimulated PBMC, but suppressed IL-10 nlRNA accumulation in these cells, thus extending our preliminary observation that IL-13 differentially regulates IL1Ra and IL-10 synthesis in LPS-stimulated monocytes.' Because IL-13 favors synthesis of IL-1Ra over the synthesis of IL-1 regardless of the inflammatory stimulus, our present results suggest that IL-13 could exert its anti-inflammatory properties in various inflammatory settings.
The anti-inflammatory properties of IL-13 may be of therapeutic interest in diseases in which IL-1 is thought to be a key mediator, such as acute myeloid leukemia," inflammatory bowel and rheumatoid arthriti~.~' Regarding the latter condition, IL-4 has been shown to reduce chronic synovial inflammation in a rat model of arthriti~.~' Because administration of recombinant human IL-4 to cancer patients results in increased levels of circulating IL-I Ra,I4 42 future clinical trials should confirm the anti-inflammatory properties of IL-13 we observed in vitro. However, because IL-13 does not act on T cells,26 IL-13 should display a more selective repertoire of biologic activities than IL-4.
